171 related articles for article (PubMed ID: 16314228)
1. Iron status and clinical outcome in patients with coronary artery disease after coronary stenting.
Ndrepepa G; Braun S; Dibra A; Mehilli J; Vogt W; Schömig A; Kastrati A
Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):418-25. PubMed ID: 16314228
[TBL] [Abstract][Full Text] [Related]
2. Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents.
Elezi S; Dibra A; Mehilli J; Pache J; Wessely R; Schömig A; Kastrati A
J Am Coll Cardiol; 2006 Oct; 48(7):1304-9. PubMed ID: 17010786
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting.
Braun S; Ndrepepa G; von Beckerath N; Mehilli J; Gorchakova O; Vogt W; Schömig A; Kastrati A
Am Heart J; 2005 Sep; 150(3):550-6. PubMed ID: 16169339
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
[TBL] [Abstract][Full Text] [Related]
6. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes.
Mojiminiyi OA; Marouf R; Abdella NA
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):559-66. PubMed ID: 18063352
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
8. Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes.
Pinkau T; Mann JF; Ndrepepa G; Mehilli J; Hadamitzky M; Braun S; Kastrati A; Schömig A
Am J Kidney Dis; 2004 Oct; 44(4):627-35. PubMed ID: 15384013
[TBL] [Abstract][Full Text] [Related]
9. Sex-associated differences in clinical outcomes after coronary stenting in patients with diabetes mellitus.
Ndrepepa G; Mehilli J; Bollwein H; Pache J; Schömig A; Kastrati A
Am J Med; 2004 Dec; 117(11):830-6. PubMed ID: 15589486
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
[TBL] [Abstract][Full Text] [Related]
11. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
[TBL] [Abstract][Full Text] [Related]
12. Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort.
Szük T; Gyöngyösi M; Homorodi N; Kristóf E; Király C; Edes IF; Facskó A; Pavo N; Sodeck G; Strehblow C; Farhan S; Maurer G; Glogar D; Domanovits H; Huber K; Edes I
Am Heart J; 2007 Feb; 153(2):289-95. PubMed ID: 17239691
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
[TBL] [Abstract][Full Text] [Related]
14. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.
Bair TL; Muhlestein JB; May HT; Meredith KG; Horne BD; Pearson RR; Li Q; Jensen KR; Anderson JL; Lappé DL
Circulation; 2007 Sep; 116(11 Suppl):I226-31. PubMed ID: 17846308
[TBL] [Abstract][Full Text] [Related]
15. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis.
Thiele H; Neumann-Schniedewind P; Jacobs S; Boudriot E; Walther T; Mohr FW; Schuler G; Falk V
J Am Coll Cardiol; 2009 Jun; 53(25):2324-31. PubMed ID: 19539141
[TBL] [Abstract][Full Text] [Related]
17. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.
Jeong YH; Hong MK; Lee CW; Park DW; Kim YH; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2008 Mar; 125(1):36-40. PubMed ID: 17521753
[TBL] [Abstract][Full Text] [Related]
18. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
Das P; Moliterno DJ; Charnigo R; Mukherjee D; Steinhubl SR; Sneed JD; Booth DC; Ziada KM
J Invasive Cardiol; 2006 Sep; 18(9):405-8. PubMed ID: 16954577
[TBL] [Abstract][Full Text] [Related]
19. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
20. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
Assali AR; Moustapha A; Sdringola S; Denktas AE; Willerson JT; Holmes DR; Smalling RW
Am J Cardiol; 2006 Sep; 98(6):729-33. PubMed ID: 16950172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
